Initial studies of a new type of vaginal gel has been encouraging to researchers, as the AIDS virus has been blocked in monkey studies from a commonly used ingredient used in cosmetics.
The gel is named glycerol monolaurate or GML, and is already approved by the FDA for use.
When experimenting with five rhesus macaque monkeys, results were that no immediate signs of AIDS were seen in the monkeys after being treated with GML. One monkey did have symptoms of the disease several months later.
It’s thought that GML will be most effective when used as a “cocktail” as in other agents used to battle AIDS.
What's Driving This Trend
- AIDS Prevention Gels
- GML-based vaginal gels show potential in blocking AIDS in monkeys.
- Cosmetics as Medicine
- The use of cosmetic ingredients for medical purposes reveals an opportunity for cross-industry innovation.
- Combination Therapies for AIDS
- GML may become part of combination therapies for AIDS prevention and treatment.
Who This Affects Most
- Pharmaceuticals
- The pharmaceutical industry can look into GML-based products for AIDS prevention.
- Cosmetics
- The cosmetics industry can explore the medical applications of their products, such as using GML for AIDS prevention.
- Biotechnology
- The biotech industry can develop combination therapies for AIDS with GML as one of the components.
